Analystreport

Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) had its "buy" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $8.00 price target on the stock.

Catalyst Pharmaceuticals, Inc.  (CPRX) 
Last catalyst pharmaceuticals, inc. earnings: 3/16 05:26 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.catalystpharma.com